KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Land & Improvements (2017 - 2019)

Historic Land & Improvements for Takeda Pharmaceutical (TAK) over the last 3 years, with Q1 2019 value amounting to $312.1 million.

  • Takeda Pharmaceutical's Land & Improvements changed N/A to $312.1 million in Q1 2019 from the same period last year, while for Mar 2019 it was $312.1 million, marking a year-over-year change of. This contributed to the annual value of $312.1 million for FY2019, which is N/A changed from last year.
  • Per Takeda Pharmaceutical's latest filing, its Land & Improvements stood at $312.1 million for Q1 2019.
  • Takeda Pharmaceutical's 5-year Land & Improvements high stood at $332.3 million for Q4 2017, and its period low was $295.6 million during Q4 2018.
  • Its 3-year average for Land & Improvements is $313.3 million, with a median of $312.1 million in 2019.
  • Over the last 5 years, Takeda Pharmaceutical's Land & Improvements had its largest YoY gain of 1104.42% in 2018, and its largest YoY loss of 1104.42% in 2018.
  • Quarter analysis of 3 years shows Takeda Pharmaceutical's Land & Improvements stood at $332.3 million in 2017, then fell by 11.04% to $295.6 million in 2018, then grew by 5.6% to $312.1 million in 2019.
  • Its Land & Improvements stands at $312.1 million for Q1 2019, versus $295.6 million for Q4 2018 and $332.3 million for Q4 2017.